ArticleFrontiers in surgery2026
Clinical application of the F21 multipurpose cystoscope with continuous irrigation capability in photoselective vaporization of the prostate: a retrospective controlled study.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate whether an F21 multipurpose cystoscope with continuous irrigation capability is associated with a lower incidence of postoperative urethral stricture after photoselective vaporization of the prostate (PVP), while maintaining satisfactory short-term functional outcomes. Methods: This single-center retrospective comparative cohort included consecutive male patients aged ≥60 years who underwent PVP between January 2024 and January 2025. Procedures were performed using either the F21 multipurpose cystoscope with continuous irrigation capability or a conventional F26 resectoscope. All patients underwent standardized postoperative follow-up at 3 and 6 months, including assessment of the International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax), postvoid residual urine volume (PVR), and clinical symptoms suggestive of urethral stricture. Postoperative urethroscopy was not performed routinely in all asymptomatic patients; instead, diagnostic urethroscopy was performed in patients with new or persistent obstructive voiding symptoms, a marked decrease in Qmax, increased PVR, or clinical suspicion of urethral stricture. Urethral stricture was defined as obstructive voiding symptoms combined with endoscopic confirmation of urethral narrowing with a caliber of <15 Fr. Between-group comparisons and multivariable logistic regression were used to assess the association between instrument type and urethral stricture while accounting for clinically relevant covariates. Results: A total of 240 patients were included, of whom 50 underwent PVP with the F21 instrument and 190 with the F26 resectoscope. Baseline characteristics and key perioperative variables were comparable between groups. Both groups showed marked postoperative improvement in IPSS and Qmax. Compared with the F26 group, the F21 group had significantly lower PVR at 3 months (2.316 ± 11.463 vs. 6.559 ± 16.714 mL, Conclusion: In this retrospective cohort study, the use of the F21 multipurpose cystoscope with continuous irrigation capability during PVP was associated with a lower rate of clinically detected postoperative urethral stricture and improved postoperative bladder emptying, while maintaining short-term improvements in urinary symptoms and urinary flow. However, given the retrospective design, symptom-triggered urethroscopic confirmation, and limited 6-month follow-up period, these findings should be interpreted as short-term, hypothesis-generating clinical evidence. Because urethral strictures may occur beyond 6 months after surgery, further prospective studies with longer follow-up periods, ideally at least 12-24 months, are warranted to validate these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.